Penn spinout developing cancer treatments raises $1M

Pinpoint Therapeutics, a University of Pennsylvania spinout focused on developing cancer treatments, has raised $1 million in debt financing. The debt sale was disclosed in documents filed with the U.S. Securities and Exchange Commission. Pinpoint was founded in 2018 by researchers Ravi Amaravadi and Jeffrey D. Winkler from Penn's Abramson Cancer Center to commercialize their technology for developing potential new cancer treatments. The Abramson researchers have identified an enzyme, called PPT1,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news